Home page Home page
AstraZeneca

Vipdomet
alogliptin, metformin

Package leaflet: Information for the patient


Vipdomet 12.5 mg/850 mg film-coated tablets Vipdomet 12.5 mg/1000 mg film-coated tablets alogliptin/metformin hydrochloride


Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.


Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the nationalreportingsystem listedin AppendixV. By reporting side effects you can help provide more information on the safety of this medicine.


  1. How to store Vipdomet


    Keep this medicine out of the sight and reach of children.


    Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.


    This medicinal product does not require any special storage conditions.


    Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.


  2. Contents of the pack and other information What Vipdomet contains

- The active substances are alogliptin and metformin hydrochloride.

Each 12.5 mg/850 mg film-coated tablet contains alogliptin benzoate equivalent to 12.5 mg alogliptin and 850 mg metformin hydrochloride.

Each 12.5 mg/1,000 mg film-coated tablet contains alogliptin benzoate equivalent to 12.5 mg

alogliptin and 1,000 mg metformin hydrochloride.

- The other ingredients are mannitol, microcrystalline cellulose, povidone K30, crospovidone Type A, magnesium stearate, hypromellose, talc, titanium dioxide (E171) and yellow iron oxide (E172).


What Vipdomet looks like and contents of the pack


Vipdomet is available in blister packs containing 10, 14, 20, 28, 56, 60, 98, 112, 120, 180, 196, 200 tablets and in multipacks comprising 2 packs each containing 98 film-coated tablets.


Not all pack sizes may be marketed.


Marketing Authorisation Holder

Takeda Pharma A/S Delta Park 45

2665 Vallensbaek Strand Denmark


Manufacturer

Takeda Ireland Limited Bray Business Park Kilruddery

Co. Wicklow Ireland


For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:


België/Belgique/Belgien

Takeda Belgium

Tél/Tel: +32 2 464 06 11

takeda-belgium@takeda.com

Lietuva

Takeda UAB

Tel: +370 521 09 070


България

Такеда България

Тел.: +359 2 958 27 36; +359 2 958 15 29

Luxembourg/Luxemburg

Takeda Belgium

Tél/Tel: +32 2 464 06 11

takeda-belgium@takeda.com


Česká republika

Takeda Pharmaceuticals Czech Republic s.r.o. Tel: +420 234 722 722

Magyarország Takeda Pharma Kft. Tel: +361 2707030


Danmark

Takeda Pharma A/S Tlf/Tel: +45 46 77 11 11

Malta

TAKEDA HELLAS S.A. Tel: +30 210 6387800

gr.info@takeda.com


Deutschland

Takeda GmbH

Tel: +49 (0) 800 825 3325

medinfoEMEA@takeda.com

Nederland

Takeda Nederland B.V.

Tel: +31 20 203 5492

medinfoEMEA@takeda.com

Eesti

Takeda Pharma AS Tel: +372 6177 669

Norge

Takeda AS

Tlf: +47 6676 3030

infonorge@takeda.com


Ελλάδα

TAKEDA ΕΛΛΑΣ Α.Ε. Τηλ: +30 210 6387800

gr.info@takeda.com

Österreich

Takeda Pharma Ges. m.b.H. Tel: +43 (0) 800-20 80 50


España

Laboratorios Menarini, S.A. Tel: +34 934 628 800

info@menarini.es

Polska

Takeda Pharma sp. z o.o. Tel. +48 22 608 13 00


France

Takeda France SAS Tél: +33 1 40 67 33 00

medinfoEMEA@takeda.com

Portugal

Takeda Farmacêuticos Portugal, Lda. Tel: +351 21 120 1457


Hrvatska

Takeda Pharmaceuticals Croatia d.o.o Tel: +385 1 377 88 96

România

Takeda Pharmaceuticals SRL Tel: +40 21 335 03 91


Ireland

Takeda Products Ireland Limited Tel: 1800 937 970

medinfoEMEA@takeda.com

Slovenija

Takeda Pharmaceuticals farmacevtska družba d.o.o. Tel: +386 (0) 59 082 480


Ísland

Vistor hf.

Sími: +354 535 7000

vistor@vistor.is

Slovenská republika

Takeda Pharmaceuticals Slovakia s.r.o. Tel: +421 (2) 20 602 600


Italia

Takeda Italia S.p.A. Tel: +39 06 502601

Suomi/Finland

Takeda Oy

Tel. +358 20 746 5000


Κύπρος

TAKEDA ΕΛΛΑΣ Α.Ε. Τηλ: +30 210 6387800

gr.info@takeda.com

Sverige

Takeda Pharma AB Tel: +46 8 731 28 00

infosweden@takeda.com


Latvija

Takeda Latvia SIA Tel: +371 67840082

United Kingdom (Northern Ireland)

Takeda UK Ltd

Tel: +44 (0) 2830 640 902

medinfoEMEA@takeda.com


This leaflet was last revised in